Adjuvant FOLFIRI Based-chemotherapy After Resection of CLM Responding to Preoperative FOLFIRI

Adjuvant FOLFIRI Based-chemotherapy After Resection of CLM Responding to Preoperative FOLFIRI is a phase 3, randomised interventional study registered as NCT06501482 by Assistance Publique - Hôpitaux de Paris, with a registry enrolment figure of 254 participants, started 2025-06-27 and due to reach its primary completion in 2028-06-27. Interventions recorded: Postoperative reintroduction of FOLFIRI based chemotherapy. Conditions listed: Colorectal Cancer; Colorectal Liver Metastases. Primary outcome: The disease-free survival rate. Colorectal eligibility wording from the registry: "For this study, metachronous CLM is defined as liver recurrence occurring more than 12 months after treatment of the primary colorectal cancer". Sites: France. No results are recorded here; the registry entry is the source.